Cargando…

Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial

BACKGROUND: The Global Programme for the Elimination of Lymphatic Filariasis (GPELF) has been in operation since the year 2000, with the aim of eliminating the disease by the year 2020, following five to six rounds of effective annual mass drug administration (MDA). The treatment regimen is ivermect...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Dziedzom K., Ahorlu, Collins S., Adu-Amankwah, Susan, Otchere, Joseph, Mensah, Sedzro K., Larbi, Irene A., Mensah, George E., Biritwum, Nana-Kwadwo, Boakye, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625710/ https://www.ncbi.nlm.nih.gov/pubmed/28969715 http://dx.doi.org/10.1186/s13063-017-2196-9

Ejemplares similares

An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa
por: de Souza, Dziedzom Komi, et al.
Publicado: (2017)

Effects of lyophilization and storage temperature on Wuchereria bancrofti antigen sensitivity and stability
por: Agbozo, Edem Y., et al.
Publicado: (2018)

Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin
por: Mnkai, Jonathan, et al.
Publicado: (2022)

Transmission of Wuchereria Bancrofti
por: Mohindra, B. P.
Publicado: (1948)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d’Ivoire
por: Edi, Constant, et al.
Publicado: (2019)

The epidemiology of lymphatic filariasis in Ghana, explained by the possible existence of two strains of Wuchereria bancrofti
por: de Souza, Dziedzom Komi, et al.
Publicado: (2014)

Hydrocele due to Wuchereria bancrofti Infection
por: Takaya, Saho, et al.
Publicado: (2018)

The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration
por: de Souza, Dziedzom K., et al.
Publicado: (2015)

A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India
por: Kar, Shantanu Kumar, et al.
Publicado: (2015)

Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea
por: Kouassi, Bernard L., et al.
Publicado: (2015)

The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study
por: Turner, Hugo C., et al.
Publicado: (2013)

Low Microfilaremia Levels in Three Districts in Coastal Ghana with at Least 16 Years of Mass Drug Administration and Persistent Transmission of Lymphatic Filariasis
por: de Souza, Dziedzom K., et al.
Publicado: (2018)

Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity
por: Richards, FO, et al.
Publicado: (2005)

Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti
por: Debrah, Linda Batsa, et al.
Publicado: (2017)

Assessing the Presence of Wuchereria bancrofti Infections in Vectors Using Xenomonitoring in Lymphatic Filariasis Endemic Districts in Ghana
por: Pi-Bansa, Sellase, et al.
Publicado: (2019)

Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
por: Tamadaho, Ruth S. E., et al.
Publicado: (2023)

Plasmodium knowlesi and Wuchereria bancrofti: Their Vectors and Challenges for the Future
por: Vythilingam, Indra
Publicado: (2012)

Records of Findings of Adult Wuchereria (Filaria) Bancrofti in India
por: Rao, S. Sundar
Publicado: (1930)

The Duration of the Life of the Embryos of Wuchereria Bancrofti in the Human System
por: Rao, S. Sundar
Publicado: (1933)

Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment
por: Kar, Shantanu K., et al.
Publicado: (2017)

Mansonia africana and Mansonia uniformis are Vectors in the transmission of Wuchereria bancrofti lymphatic filariasis in Ghana
por: Ughasi, Josephine, et al.
Publicado: (2012)

Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges
por: de Souza, Dziedzom K., et al.
Publicado: (2020)

Concomitant infections of Plasmodium falciparum and Wuchereria bancrofti on the Kenyan coast
por: Muturi, Ephantus J, et al.
Publicado: (2006)

A Systematic Study on Structure and Function of ATPase of Wuchereria bancrofti
por: Islam, Md. Saiful, et al.
Publicado: (2014)

Filarial Orchitis due to Wuchereria bancrofti Masquerading as Testicular Neoplasm
por: Patne, Shashikant C. U., et al.
Publicado: (2016)

Evaluation of Actin-1 Expression in Wild Caught Wuchereria bancrofti-Infected Mosquito Vectors
por: Entonu, Moses Edache, et al.
Publicado: (2020)

Detection of Wuchereria bancrofti in human blood samples and mosquitoes in Matayos, Busia County-Kenya
por: Kinyatta, Nancy, et al.
Publicado: (2023)

Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment
por: Ahorlu, Collins S. K., et al.
Publicado: (2018)

Monitoring lymphatic filariasis interventions: Adult mosquito sampling, and improved PCR – based pool screening method for Wuchereria bancrofti infection in Anopheles mosquitoes
por: Boakye, Daniel A, et al.
Publicado: (2007)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Evaluation of Wuchereria bancrofti GST as a Vaccine Candidate for Lymphatic Filariasis
por: Veerapathran, Anandharaman, et al.
Publicado: (2009)

Elevated Adaptive Immune Responses Are Associated with Latent Infections of Wuchereria bancrofti
por: Arndts, Kathrin, et al.
Publicado: (2012)

Identification of Wb123 as an Early and Specific Marker of Wuchereria bancrofti Infection
por: Kubofcik, Joseph, et al.
Publicado: (2012)

Draft genome sequence of the Wolbachia endosymbiont of Wuchereria bancrofti wWb
por: Chung, Matthew, et al.
Publicado: (2017)

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections
por: Greene, Sarah E., et al.
Publicado: (2022)

Increased HIV Incidence in Wuchereria bancrofti Microfilaria Positive Individuals in Tanzania
por: Mnkai, Jonathan, et al.
Publicado: (2023)

Wuchereria bancrofti transmission pattern in southern Mali prior to and following the institution of mass drug administration
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2013)

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study
por: Pani, SP, et al.
Publicado: (2002)

Assessing Lymphatic Filariasis Data Quality in Endemic Communities in Ghana, Using the Neglected Tropical Diseases Data Quality Assessment Tool for Preventive Chemotherapy
por: de Souza, Dziedzom K., et al.
Publicado: (2016)

Modeling analysis of GST (glutathione-S-transferases) from Wuchereria bancrofti and Brugia malayi
por: Bhargavi, Rayavarapu, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_1qfpi4s4urke66v6cnsg6ulh0e